Medicare Enrolled
Dr. Ashok Verma, M.D.
Interventional Cardiology · Hanford, CA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Verma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Verma?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Verma
Dr. Ashok Verma is an interventional cardiology specialist in Hanford, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Verma performed 10,170 Medicare services across 7,694 unique beneficiaries.
Between the years covered by Open Payments, Dr. Verma received a total of $5,762 from 32 pharmaceutical and/or device companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Verma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in CA
$5,762 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,170
Medicare services
Top 9% in CA for interventional cardiology
7,694
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~508 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,383 | $11 | $92 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,305 | $94 | $250 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,004 | $44 | $116 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
964 | $6 | $22 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
892 | $69 | $148 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
766 | $147 | $752 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
710 | $34 | $330 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
394 | $17 | $110 |
| Exercise or drug-induced heart stress test with ECG A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate. |
394 | $24 | $110 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
394 | $11 | $110 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
355 | $376 | $1,386 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
242 | $118 | $337 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
139 | $17 | $62 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
139 | $71 | $301 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
139 | $142 | $296 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
124 | $56 | $289 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
104 | $20 | $62 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
100 | $26 | $113 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
94 | $10 | $165 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
67 | $60 | $100 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
66 | $21 | $46 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
58 | $82 | $250 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
58 | $94 | $278 |
| Cardiac catheterization | 52 | $190 | $1,909 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
35 | $26 | $121 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
33 | $137 | $408 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
32 | $23 | $96 |
| Programming of single lead implantable defibrillator system Adjustment and testing of the settings for a single-lead implantable cardioverter-defibrillator (ICD) to ensure proper function. |
29 | $31 | $120 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
24 | $402 | $2,310 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
23 | $58 | $147 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
20 | $21 | $110 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
20 | $729 | $1,375 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $165 | $2,106 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.7% high complexity
33.3% medium
54.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,762
Total received (2018-2024)
Avg $823/year across 7 years
Bottom 48% in CA for interventional cardiology
32
Companies
278
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,762 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$984
2023
$1,436
2022
$1,056
2021
$606
2020
$288
2019
$535
2018
$858
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$392
Boston Scientific Corporation
$191
Merck Sharp & Dohme LLC
$91
ABIOMED
$56
Regeneron Healthcare Solutions, Inc.
$48
E.R. Squibb & Sons, L.L.C.
$41
SCPHARMACEUTICALS INC.
$31
AstraZeneca Pharmaceuticals LP
$29
Edwards Lifesciences Corporation
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Kiniksa Pharmaceuticals International, plc
$19
Novartis Pharmaceuticals Corporation
$18
Lexicon Pharmaceuticals, Inc.
$18
Top 3 companies account for 68.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,067
Novartis Pharmaceuticals Corporation
$543
AstraZeneca Pharmaceuticals LP
$529
Boston Scientific Corporation
$527
ABIOMED
$234
Merck Sharp & Dohme LLC
$231
Inari Medical, Inc.
$203
Boehringer Ingelheim Pharmaceuticals, Inc.
$193
Abbott Laboratories
$187
Lexicon Pharmaceuticals, Inc.
$118
PFIZER INC.
$101
Medtronic Vascular, Inc.
$79
Janssen Pharmaceuticals, Inc
$70
Regeneron Healthcare Solutions, Inc.
$70
SCPHARMACEUTICALS INC.
$70
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$65
CVRx, Inc.
$60
Medtronic, Inc.
$57
E.R. Squibb & Sons, L.L.C.
$56
Baxter Healthcare
$45
Artivion, Inc.
$43
ARBOR PHARMACEUTICALS, INC.
$31
BOSTON SCIENTIFIC CORPORATION
$28
Edwards Lifesciences Corporation
$26
Otsuka America Pharmaceutical, Inc.
$21
Amarin Pharma Inc.
$20
SUN PHARMACEUTICAL INDUSTRIES INC.
$20
Kiniksa Pharmaceuticals International, plc
$19
Novo Nordisk Inc
$15
Kiniksa Pharmaceuticals, Ltd.
$13
Cardiovascular Systems Inc.
$11
Penumbra, Inc.
$10
Top 3 companies account for 54.5% of all-time payments
Associated products mentioned in payments ›
ACCOLADE · AFINITOR · Arcalyst · Assurity Pacemaker · Azure · BRILINTA · Barostim Neo System · Bidil · CAMZYOS · CONFIRM RX · COROFLOW · Corlanor · Coronary Orbital Atherectomy System · ELIQUIS · ENTRESTO · EVKEEZA · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · FlowTriever · Hillrom - Cardiac Ambulatory Monitor · INGEVITY · Impella · Indigo System · Inpefa · JARDIANCE · KAPSPARGO · LATITUDE · LEQVIO · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MITRACLIP · MitraClip System · ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · RESONATE · REVEAL LINQ · Repatha · Reveal LINQ · SAMSCA · SQ RX PULSE GENERATOR · SQ-RX PULSE GENERATOR · SQRX PULSE GENERATOR · VERQUVO · Vascepa · VenaSeal · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
2
Per 100K population
1.3
County median income
$68,750
Nearest hospital
ADVENTIST HEALTH HANFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Verma is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Verma experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Verma performed 1,383 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Verma receive payments from pharmaceutical companies?
Yes. Dr. Verma received a total of $5,762 from 32 companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Verma's costs compare to other interventional cardiologists in Hanford?
Dr. Verma's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Verma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Hanford
Browse interventional cardiologists in Hanford ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology